Natural compounds and derivatives as Ser/Thr protein kinase modulators and inhibitors

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

115 Downloads (Pure)

Abstrakt

The need for new drugs is compelling, irrespective of the disease. Focusing on medical problems in the Western countries, heart disease and cancer are at the moment predominant illnesses. Owing to the fact that ~90% of all 21,000 cellular proteins in humans are regulated by phosphorylation/dephosphorylation it is not surprising that the enzymes catalysing these reactions (i.e., protein kinases and phosphatases, respectively) have attracted considerable attention in the recent past. Protein kinases are major team players in cell signalling. In tumours, these enzymes are found to be mutated disturbing the proper function of signalling pathways and leading to uncontrolled cellular growth and sustained malignant behaviour. Hence, the search for small-molecule inhibitors targeting the altered protein kinase molecules in tumour cells has become a major research focus in the academia and pharmaceutical companies.

OriginalsprogEngelsk
Artikelnummer4
TidsskriftPharmaceuticals
Vol/bind12
Udgave nummer1
Antal sider21
ISSN1424-8247
DOI
StatusUdgivet - 2019

Fingeraftryk

Dyk ned i forskningsemnerne om 'Natural compounds and derivatives as Ser/Thr protein kinase modulators and inhibitors'. Sammen danner de et unikt fingeraftryk.

Citationsformater